Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
fda
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
novartis
3
×
amgen
biogen
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
accent therapeutics
aducanumab
alirocumab
allergan
alnylam pharmaceuticals
What
fda
3
×
bio
medicines
new
roundup
acquire
activity
agreed
approvals
august
billion
biogen
biotech
brings
busy
cash
cholesterol
clamped
company
compound
covid
days
deal
decisions
delays
developing
devices
drug
drugs
economic
fast
including
ipo
isn’t
legacy
lot
medco
news
nods
novartis
Language
unset
3
×
Current search:
fda
×
biotech
×
unset
×
novartis
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
